Folgen
Ariel Feldstein
Ariel Feldstein
Bestätigte E-Mail-Adresse bei ucsd.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Z Wang, E Klipfell, BJ Bennett, R Koeth, BS Levison, B DuGar, ...
nature 472 (7341), 57-63, 2011
54142011
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
LA Adams, JF Lymp, JS Sauver, SO Sanderson, KD Lindor, A Feldstein, ...
Gastroenterology 129 (1), 113-121, 2005
36772005
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
MS Ascha, IA Hanouneh, R Lopez, TAR Tamimi, AF Feldstein, NN Zein
Hepatology 51 (6), 1972-1978, 2010
14762010
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ...
Gastroenterology 125 (2), 437-443, 2003
12962003
Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway
AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ...
Hepatology 40 (1), 185-194, 2004
11262004
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
A Wieckowska, NN Zein, LM Yerian, AR Lopez, AJ McCullough, ...
Hepatology 44 (1), 27-33, 2006
8702006
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
A Wree, A Eguchi, MD McGeough, CA Pena, CD Johnson, A Canbay, ...
Hepatology 59 (3), 898-910, 2014
8692014
Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
AE Feldstein, A Wieckowska, AR Lopez, YC Liu, NN Zein, AJ McCullough
Hepatology 50 (4), 1072-1078, 2009
8652009
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
AR Mridha, A Wree, AAB Robertson, MM Yeh, CD Johnson, ...
Journal of hepatology 66 (5), 1037-1046, 2017
8432017
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
AE Feldstein, P Charatcharoenwitthaya, S Treeprasertsuk, JT Benson, ...
Gut 58 (11), 1538-1544, 2009
8302009
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
A Wieckowska, BG Papouchado, ZZ Li, R Lopez, NN Zein, AE Feldstein
Official journal of the American College of Gastroenterology| ACG 103 (6 …, 2008
7362008
Triggering and resolution of inflammation in NASH
S Schuster, D Cabrera, M Arrese, AE Feldstein
Nature reviews Gastroenterology & hepatology 15 (6), 349-364, 2018
6822018
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
A Wree, L Broderick, A Canbay, HM Hoffman, AE Feldstein
Nature reviews Gastroenterology & hepatology 10 (11), 627-636, 2013
6542013
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future
A Wieckowska, AJ McCullough, AE Feldstein
Hepatology 46 (2), 582-589, 2007
5862007
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
A Canbay, AE Feldstein, H Higuchi, N Werneburg, A Grambihler, ...
Hepatology 38 (5), 1188-1198, 2003
5752003
Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase
ZZ Li, M Berk, TM McIntyre, AE Feldstein
Journal of Biological Chemistry 284 (9), 5637-5644, 2009
4852009
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
A Wree, MD McGeough, CA Peña, M Schlattjan, H Li, ME Inzaugarat, ...
Journal of molecular medicine 92, 1069-1082, 2014
4762014
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
N Alkhouri, LJ Dixon, AE Feldstein
Expert review of gastroenterology & hepatology 3 (4), 445-451, 2009
4752009
Innate immunity and inflammation in NAFLD/NASH
M Arrese, D Cabrera, AM Kalergis, AE Feldstein
Digestive diseases and sciences 61, 1294-1303, 2016
4512016
Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo‐controlled trial
CO Zein, LM Yerian, P Gogate, R Lopez, JP Kirwan, AE Feldstein, ...
Hepatology 54 (5), 1610-1619, 2011
4502011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20